SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.005-1.3%2:22 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (450)10/12/2005 8:22:21 AM
From: Mike McFarland of 557
 
Expected Total Enrollment: 40
Study start: August 2005; Expected completion: May 2008
clinicaltrials.gov
Ten investigators in ten states.

Also,

Human Gene Therapy
Adeno-Associated Virus Vectors in Clinical Trials
May 2005, Vol. 16, No. 5: 541-550

Dr. Barrie J. Carter
Targeted Genetics, Seattle, WA 98101.

..................................

Several years ago I went to an annual tgen meeting--
a co-worker friend of mine who has shares and I
both went. As long as our shares were down, we
thought we at least might as well get a free bagel.
Anyway, we met Dr. Carter and chatted very briefly
with him. That was pretty cool--he shared a funny
anecdote about aav2.

I think for a little while I gravitated toward companies
that had seemingly strong women CEO's, snap, gzmo, tgen.
Somehow, I got over it;-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext